Inhibition of the downstream ERK1/2 signaling pathway activation prevents pulmonary vascular remodeling, elevated right ventricular pressure and improves right ventricular hypertrophy in MCT- and chronic hypoxia-induced PH model [53], [54]. The gene discussed is MAPK3; the disease is Right ventricular hypertrophy.